H. pylori escape host immunoreaction through inhibiting ILK expression by VacA

Cellular and Molecular Immunology

Volumn 6, Issue 3, 2009, Pages 191-197

  Yuan, Jianping ^a,b   Li, Ping ^a   Tao, Jing ^a   Shi, Xiaodong ^a   Hu, Baoyu ^a   Chen, Huabiao ^b   Guo, Xiaokui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

H. pylori; Host immunoreaction; ILK

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; INTEGRIN LINKED KINASE; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; VACUOLATING TOXIN; BACTERIAL PROTEIN; INTEGRIN-LINKED KINASE; PROTEIN SERINE THREONINE KINASE; VACA PROTEIN, HELICOBACTER PYLORI;

ARTICLE; CELL STRAIN U937; CONTROLLED STUDY; GENE OVEREXPRESSION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PARASITE INTERACTION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; PROTEIN SYNTHESIS INHIBITION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; MACROPHAGE; MONOCYTE; NONHUMAN; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; UPREGULATION; GENETIC TRANSFECTION; GENETICS; HOST PATHOGEN INTERACTION; METABOLISM; MUTATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

HELICOBACTER PYLORI;

BACTERIAL PROTEINS; BLOTTING, WESTERN; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MUTATION; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN-SERINE-THREONINE KINASES; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; U937 CELLS; UP-REGULATION;

EID: 68549125345     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2009.26     Document Type: Article

References (42)

1. Covacci A, Telford JL, Giudice GD, Parsonnet J, Rappuoli R. Helicobacter pylori virulence and genetic geography. Science. 1999;284:1328-1333.
2. Blaser MJ. Science, medicine, and the future: Helicobacter pylori and gastric diseases. BMJ. 1998;316:1507-1510.
3. Gebert B, Fischer W, Haas R. The Helicobacter pylori vacuolating cytotoxin: from cellular vacuolation to immunosuppressive activities. Rev Physiol Biochem Pharmacol. 2004;152:205-220.
4. Boncristiano M, Paccani SR, Barone S, et al. The Helicobacter pylori vacuolating toxin inhibits T cell activation by two independent mechanisms. J Exp Med. 2003;198:1887-1897.
5. Gebert B, Fischer W, Weiss E, Hoffmann R, Haas R. Helicobacter pylori vacuolating cytotoxin inhibits T lymphocyte activation. Science. 2003;301:1099-1102.
6. Odenbreit S, Gebert B, Puls J, Fischer W, Haas R. Interaction of Helicobacter pylori with professional phagocytes: role of the cag pathogenicity island and translocation, phosphorylation and specific processing of CagA. Cell Microbiol. 2001;3:21-31.
7. Mai UE, Perez-Perez GI, Wahl LM, Wahl SM, Blaser MJ, Smith PD. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide independent mechanism. J Clin Invest. 1991;87:894-900.
8. Mai UE, Perez-Perez GI, Allen JB, Wahl SM, Blaser MJ. Smith PD. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med. 1992;175:517-525.
9. Harris PR, Ernst PB, Kawabata S, Kiyono H, Graham MF, Smith PD. Recombinant Helicobacter pylori urease activates primary mucosal macrophages. J Infect Dis. 1998;178:1516-1520.
10. Allen LA, Schlesinger LS, Kang B. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J Exp Med. 2000;191:115-128.
11. Zheng PY, Jones NL. Helicobacter pylori strains expressing the vacuolating cytotoxin interrupt phagosome maturation in macrophages by recruiting and retaining TACO (coronin 1) protein. Cell Microbiol. 2003;5:25-40.
12. Rittig MG, Shaw B, Letley DP, Thomas RJ, Argent RH, Atherton JC. Helicobacter pylori-induced homotypic phagosome fusion in human monocytes is independent of the bacterial vacA and cag status. Cell Microbiol. 2003;5:887-899.
13. Dedhar S. Cell-substrate interactions and signaling through ILK. Curr Opin Cell Biol. 2001;12:250-256. (Pubitemid 30142574)
14. González-Santiago L, López-Ongil S, Rodríguez-Puyol M, Rodríguez-Puyol D. Decreased nitric oxide synthesis in human endothelial cells cultured on type I collagen. Circ Res. 2002;90:539-545. (Pubitemid 34640903)
15. 2+/calmodulin-dependent and tetrahydrobiopterin regulatory process. J Biol Chem. 1998;273:25804-25808.
16. Yuan J, Li T, Shi X, et al. Deletion of Helicobacter pylori vacuolating cytotoxin gene by introduction of directed mutagenesis. World J Gastroenterol. 2003;9:2251-2257.
17. Hannigan GE, Leung-Hagesteijn C, Fitz-Gibbon L, et al. Regulation of cell adhesion and anchorage-dependent growth by a new β1-integrin-linked protein kinase. Nature. 1996;379:91-96. (Pubitemid 26008142)
18. Yoganathan N, Yee A, Zhang Z, et al. Integrin-linked kinase, a promising cancer therapeutic target: biochemical and biological properties. Pharmacol Ther. 2002;93:233-242. (Pubitemid 34615564)
19. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. J Biochem. 2001;357:593-615. (Pubitemid 32735142)
20. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A. 1990;87:682-685. (Pubitemid 20051434)
21. Busse R, Mulsch A. Calcium-dependent nitric oxide synthesis in endothelial cytosol is mediated by calmodulin. FEBS Lett. 1990;265:133-136. (Pubitemid 20189413)
22. Marsden PA, Heng HH, Scherer SW, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem. 1993;268:17478-17488. (Pubitemid 23236991)
23. Miyahara K, Kawamoto T, Sase K, et al. Cloning and structural characterization of the human endothelial nitric-oxide-synthase gene. Eur J Biochem. 1994;223:719-726. (Pubitemid 24263152)
24. Reiling N, Ulmer AJ, Duchrow M, Ernst M, Flad HD, Hauschildt S. Nitric oxide synthase: mRNA expression of different isoforms in human monocytes/macrophages. Eur J Immunol. 1994;24:1941-1944. (Pubitemid 24237573)
25. 2+/calmodulin- dependent isoform in human B and T lymphocytes. Eur J Immunol. 1996;26:511-516.
26. Ruiz-Torres MP, López-Ongil S, Griera M, Díez- Marqués ML, Rodríguez-Puyol M, Rodríguez-Puyol D. The accumulation of extracellular matrix in the kidney: Consequences on cellular function. J Nephrol. 2005;18:334-340. (Pubitemid 41078957)
27. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature. 1991;351:714-718. (Pubitemid 21896670)
28. Janssens SP, Shimouchi A, Quertermous T, Bloch DB, Bloch KD. Cloning and expression of a cDNA encoding human endothelium-derived relaxing factor/nitric oxide synthase. J Biol Chem. 1992;267:14519-14522.
29. Chen PF, Tsai AL, Berka V, Wu KK. Endothelial nitric-oxide synthase. Evidence for bidomain structure and successful reconstitution of catalytic activity from two separate domains generated by a baculovirus expression system. J Biol Chem. 1996;271:14631-14635. (Pubitemid 26190371)
30. Segal AW, Shatwell KP. The NADPH oxidase of phagocytic leukocytes. Ann N Y Acad Sci. 1997;832:215-222.
31. Babior BM. NADPH oxidase: an update. Blood. 1999;93:1464-1476.
32. Wang W, Wang S, Yan L, et al. Superoxide production and reactive oxygen species signaling by endothelial nitric-oxide synthase. J Biol Chem. 2000;275:16899-16903. (Pubitemid 30398927)
33. Smith RM, Curnutte JT. Molecular basis of chronic granulomatous disease. Blood. 1991;77:673-686.
34. Vazquez-Torres A, Xu Y, Jones-Carson J, et al. Salmonella pathogenicity island 2-dependent evasion of the phagocyte NADPH oxidase. Science. 2000;287:1655-1658. (Pubitemid 30127767)
35. Pedersen SS, Kharazmi A, Espersen F, Hoiby N. Pseudomonas aeruginosa alginate in cystic fibrosis sputum and the inflammatory response. Infect Immun. 1990;58:3363-3368.
36. Konig B, Friedl P, Pedersen SS, Konig W. Alginate - its role in neutrophil responses and signal transduction towards mucoid Pseudomonas aeruginosa bacteria. Int Arch Allergy Immunol. 1992;99:98-106.
37. Bylund J, Burgess LA, Cescutti P, Ernst RK, Speert DP. Exopolysaccharides from Burkholderia cenocepacia inhibit neutrophil chemotaxis and scavenge reactive oxygen species. J Biol Chem. 2006;281:2526-2532.
38. Satin B, Del Giudice G, Della Bianca V, et al. The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med. 2000;191:1467-1476.
39. Teshima S, Rokutan K, Nikawa T, Kishi K. Guinea pig gastric mucosal cells produce abundant superoxide anion through an NADPH oxidase-like system. Gastroenterology. 1998;115:1186-1196. (Pubitemid 28485610)
40. Betten A, Bylund J, Cristophe T, et al. A proinflammatory peptide from Helicobacter pylori activates monocytes to induce lymphocyte dysfunction and apoptosis. J Clin Invest. 2001;108:1221-1228.
41. Bylund J, Christophe T, Boulay F, Nystrom T, Karlsson A, Dahlgren C. Proinflammatory Activity of a Cecropin-Like antibacterial peptide from Helicobacter pylori. Antimicrob Agents Chemother. 2001;45:1700-1704.
42. Baldari CT, Lanzavecchia A, Telford JL. Immune subversion by Helicobacter pylori. Trends Immunol. 2005;26:199-207.